Search results (199)
« Back to PublicationsEthnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.
Journal article
Sarangarajan R. et al, (2021), Journal of racial and ethnic health disparities, 8, 973 - 980
Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).
Journal article
Grozinsky-Glasberg S. et al, (2020), Endocrine-related cancer, 27, R345 - R355
Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells
Journal article
Lines KE. et al, (2020), Endocrine-Related Cancer, 27, 163 - 174
Organizational Innovation for Developing New Medicines That Target Aging and Age-Related Conditions
Journal article
Ford GA. et al, (2020), The Journals of Gerontology: Series A, 75, 87 - 88
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function
Journal article
Fagan V. et al, (2019), Journal of Medicinal Chemistry, 62, 9008 - 9025
A genetics-led approach defines the drug target landscape of 30 immune-related traits
Journal article
Fang H. et al, (2019), Nature Genetics, 51, 1082 - 1091
Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy
Journal article
Wu X. et al, (2019), The Prostate, 79, 1079 - 1089
An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains
Journal article
D'Ascenzio M. et al, (2019), Angewandte Chemie International Edition, 58, 1007 - 1012
Design, Synthesis and Characterization of Covalent KDM5 Inhibitors
Journal article
Vazquez‐Rodriguez S. et al, (2019), Angewandte Chemie International Edition, 58, 515 - 519
ANGIOTENSIN 2 TYPE 2 RECEPTOR BLOCKADE IS A NOVEL TARGET FOR MURINE OSTEOARTHRITIS PAIN
Conference paper
von Loga IS. et al, (2019), OSTEOARTHRITIS AND CARTILAGE, 27, S420 - S421
Therapeutics discovery: From bench to first in-human trials*
Journal article
Al-Hujaily E. et al, (2018), Biomedical Reports
Open innovation in neuroscience research and drug discovery
Journal article
Hunter AJ. et al, (2018), Brain and Neuroscience Advances, 2
BROMODOMAIN INHIBITORS ARE POTENT EPIGENETIC REGULATORS OF CATABOLIC GENE EXPRESSION IN HUMAN OSTEOARTHRITIC CHONDROCYTES
Conference paper
de Andres MC. et al, (2018), OSTEOARTHRITIS AND CARTILAGE, 26, S154 - S154
Maximising value from a United Kingdom Biomedical Research Centre: study protocol
Journal article
Greenhalgh T. et al, (2017), Health Research Policy and Systems, 15